: Liver disease is a cause of substantial morbidity and mortality in the U.S. and cholestasis (impairment of bile flow) is a common and devastating manifestation of liver disease. This is an application to renew a grant focused on increasing our understanding of the biological causes of cholestasis, and more specifically, the role of the FIC1 (ATP8B1) protein in health and disease. Mutations in the gene encoding FIC1 (a P-type ATPase) have previously been identified as the genetic etiology of some cases of progressive familial intrahepatic cholestasis (PFIC) and benign recurrent intrahepatic cholestasis (BRIC). A mouse model of FIC1 disease has been generated and partially characterized, resulting in the novel finding that excessive bile salt resorption may contribute to development of cholestasis. The phenotype of Fic 1-deficient mice differs depending upon the murine strain background, indicating the existence of genetic modifiers of the murine Fic 1-deficient phenotype. Similarly, human patients who share the same FIC1 mutation can have widely varying severity of disease. Mapping and identification of modifier loci for the murine Fic 1-deficient phenotype will illuminate the biological role of FIC1, and may identify candidate susceptibility loci for development and progression of FIC1 disease, as well as more common disorders of complex etiology. This proposal focuses on use of genetic and candidate gene approaches to identification of modifier loci influencing strain-specific phenotypic differences, including weight at weaning, and response to bile salt supplemented diet, in Fic1 mutant mice.
In Specific Aim 1, we will perform further phenotypic characterization of the Fic1 mutant mice in C57B1/6, 129S1, and 129S4 strain backgrounds. Results of these studies will inform Specific Aims 2-4.
In Specific Aim 2, we will genetically map modifier loci for phenotypic traits of Fic1 mutant mice that differ between the C57B1/6 and 129 strains.
In Specific Aim 3, we will use genetic, candidate gene, and other approaches to further characterize 3 of these loci, with the goal of identifying a strong candidate gene for one or more of the modifier loci.
In Specific Aim 4, we will more precisely define the genomic regions thought to differ between the 129S1 and 129S4 strains, and perform targeted studies to correlate phenotypic and genotypic findings in Fic1 mutant mice of 129S1, 129S4, and mixed 129S1;129S4 strain backgrounds.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK050697-08A2
Application #
6927727
Study Section
Hepatobiliary Pathophysiology Study Section (HBPP)
Program Officer
Karp, Robert W
Project Start
1996-02-01
Project End
2010-04-30
Budget Start
2005-05-01
Budget End
2006-04-30
Support Year
8
Fiscal Year
2005
Total Cost
$249,383
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Shah, Sohela; Sanford, Ukina R; Vargas, Julie C et al. (2010) Strain background modifies phenotypes in the ATP8B1-deficient mouse. PLoS One 5:e8984
Pawlikowska, Ludmila; Strautnieks, Sandra; Jankowska, Irena et al. (2010) Differences in presentation and progression between severe FIC1 and BSEP deficiencies. J Hepatol 53:170-8
Strautnieks, Sandra S; Byrne, Jane A; Pawlikowska, Ludmila et al. (2008) Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology 134:1203-14
Knisely, A S; Strautnieks, Sandra S; Meier, Yvonne et al. (2006) Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency. Hepatology 44:478-86
Paulusma, Coen C; Groen, Annemiek; Kunne, Cindy et al. (2006) Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport. Hepatology 44:195-204
Klomp, Leo W J; Vargas, Julie C; van Mil, Saskia W C et al. (2004) Characterization of mutations in ATP8B1 associated with hereditary cholestasis. Hepatology 40:27-38
van Mil, Saskia W C; van der Woerd, Wendy L; van der Brugge, Gerda et al. (2004) Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 127:379-84
Carlton, Victoria E H; Pawlikowska, Ludmila; Bull, Laura N (2004) Molecular basis of intrahepatic cholestasis. Ann Med 36:606-17
Pawlikowska, Ludmila; Groen, Annemiek; Eppens, Elaine F et al. (2004) A mouse genetic model for familial cholestasis caused by ATP8B1 mutations reveals perturbed bile salt homeostasis but no impairment in bile secretion. Hum Mol Genet 13:881-92
Bull, Laura N (2002) Hereditary forms of intrahepatic cholestasis. Curr Opin Genet Dev 12:336-42

Showing the most recent 10 out of 16 publications